FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 21 filers reported holding FATE THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,247,000 | -46.6% | 692,900 | 0.0% | 0.01% | -38.1% |
| Q4 2015 | $2,335,000 | -36.8% | 692,900 | 0.0% | 0.02% | -43.2% |
| Q3 2015 | $3,693,000 | -17.6% | 692,900 | 0.0% | 0.04% | +12.1% |
| Q2 2015 | $4,483,000 | +32.3% | 692,900 | 0.0% | 0.03% | +13.8% |
| Q1 2015 | $3,388,000 | -2.8% | 692,900 | 0.0% | 0.03% | -12.1% |
| Q4 2014 | $3,485,000 | -1.4% | 692,900 | 0.0% | 0.03% | -10.8% |
| Q3 2014 | $3,534,000 | -19.2% | 692,900 | 0.0% | 0.04% | -27.5% |
| Q2 2014 | $4,372,000 | -35.2% | 692,900 | 0.0% | 0.05% | -38.6% |
| Q1 2014 | $6,749,000 | +53.1% | 692,900 | -1.3% | 0.08% | +27.7% |
| Q4 2013 | $4,409,000 | – | 702,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |